Skip to content
Clinical Trials – home
Cyclo Therapeutics Inc.
Sponsor

Cyclo Therapeutics Inc.

United States 6714 Northwest 16th Street, 32653-3975, United States

About the sponsor

Cyclo Therapeutics Inc. focuses on clinical research in early Alzheimer’s disease, with attention to therapeutic options aimed at preserving cognitive function and addressing disease progression in the early stages of illness.

  • Alzheimer’s disease
  • Cognitive impairment
  • Neuroprotection

Its work in this area reflects interest in treatments designed for patients with early symptomatic neurodegeneration.

About Specializations

Cyclo Therapeutics Inc. runs clinical trials in conditions such as Dementia Alzheimer's type, Niemann-Pick disease, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Dementia Alzheimer's type

Not yet recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Hydroxypropylbetadex
  • Sponsor:Cyclo Therapeutics Inc.

Niemann-Pick disease

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Hydroxypropylbetadex
  • Sponsor:Cyclo Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.